The Roles of Molecular Techniques in the Diagnosis and Management of Follicular Lymphoma

  • W. Richard Burack
Part of the Molecular Pathology Library book series (MPLB, volume 4)


The first section of this chapter is an overview focused on the practical applications intended for trainees and nonspecialist practitioners. The second section reviews how the parameters assessed in molecular genetic assays reflect the parthenogenesis of follicular lymphoma (FL).


Follicular Lymphoma Germinal Center National Comprehensive Cancer Network Class Switch Recombination Molecular Genetic Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Cook JR, Shekhter-Levin S, Swerdlow SH. Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas: results of 279 consecutive lymph node/extranodal tissue biopsies. Am J Clin Pathol. 2004;121(6):826–835.CrossRefPubMedGoogle Scholar
  2. 2.
    Janz S, Potter M, Rabkin CS. Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer. 2003;36(3):211–223.CrossRefPubMedGoogle Scholar
  3. 3.
    Rawstron AC, Bennett FL, O’Connor SJ. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008;359(6):575–583.CrossRefPubMedGoogle Scholar
  4. 4.
    Zelenetz AD, Horwitz SM, Kim YH. Non-Hodgkin’s lymphomas. NCCN clinical practice guidelines in oncology. 2008 [cited 3/18/2008]. Available at:
  5. 5.
    Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations in cancer. 2008 [cited 3/14/2008]. Available at:
  6. 6.
    Vaandrager JW, Schuuring E, Raap T, Philippo K, Kleiverda K, Kluin P. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes. Genes Chromosomes Cancer. 2000;27(1):85–94.CrossRefPubMedGoogle Scholar
  7. 7.
    Belaud-Rotureau MA, Parrens M, Carrere N. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma. Hum Pathol. 2007;38(2):365–372.CrossRefPubMedGoogle Scholar
  8. 8.
    Einerson RR, Kurtin PJ, Dayharsh GA, Kimlinger TK, Remstein ED. FISH is superior to PCR in detecting t(14;18)(q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples. Am J Clin Pathol. 2005;124(3):421–429.CrossRefPubMedGoogle Scholar
  9. 9.
    Espinet B, Bellosillo B, Melero C. FISH is better than BIOMED-2 PCR to detect IgH/BCL2 translocation in follicular lymphoma at diagnosis using paraffin-embedded tissue sections. Leuk Res. 2008;32(5):737–742.CrossRefPubMedGoogle Scholar
  10. 10.
    Aster JC, Longtine JA. Detection of BCL2 rearrangements in follicular lymphoma. Am J Pathol. 2002;160(3):759–763.PubMedGoogle Scholar
  11. 11.
    van Dongen JJ, Langerak AW, Brüggemann M. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98–3936. Leukemia. 2003;17(12):2257–2317.CrossRefPubMedGoogle Scholar
  12. 12.
    Halldorsdottir AM, Zehnbauer BA, Burack WR. Application of BIOMED-2 clonality assays to formalin-fixed paraffin embedded follicular lymphoma specimens: superior performance of the IGK assays compared to IGH for suboptimal specimens. Leuk Lymphoma. 2007;48(7):1338–1343.CrossRefPubMedGoogle Scholar
  13. 13.
    Bende RJ, Smit LA, van Noesel CJ. Molecular pathways in follicular lymphoma. Leukemia. 2007;21(1):18–29.CrossRefPubMedGoogle Scholar
  14. 14.
    Küppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341(20):1520–1529.CrossRefPubMedGoogle Scholar
  15. 15.
    Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5(4):251–262.CrossRefPubMedGoogle Scholar
  16. 16.
    Margalit O, Amram H, Amariglio N. BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma. Blood. 2006;107(4):1599–1607.CrossRefPubMedGoogle Scholar
  17. 17.
    Phan RT, Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature. 2004;432(7017):635–639.CrossRefPubMedGoogle Scholar
  18. 18.
    Raghavan SC, Swanson PC, Wu X, Hsieh CL, Lieber MR. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex. Nature. 2004;428(6978):88–93.CrossRefPubMedGoogle Scholar
  19. 19.
    Roulland S, Navarro JM, Grenot P. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med. 2006;203(11):2425–2431.CrossRefPubMedGoogle Scholar
  20. 20.
    Staudt LM. A closer look at follicular lymphoma. N Engl J Med. 2007;356(7):741–742.CrossRefPubMedGoogle Scholar
  21. 21.
    Oeschger S, Bräuninger A, Küppers R, Hansmann ML. Tumor cell dissemination in follicular lymphoma. Blood. 2002;99(6):2192–2198.CrossRefPubMedGoogle Scholar
  22. 22.
    Hardianti MS, Tatsumi E, Syampurnawati M. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL. Leukemia. 2004;18(4):826–831.CrossRefPubMedGoogle Scholar
  23. 23.
    Pasqualucci L, Neumeister P, Goossens T. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001;412(6844):341–346.CrossRefPubMedGoogle Scholar
  24. 24.
    Halldórsdóttir AM, Frühwirth M, Deutsch A. Quantifying the role of aberrant somatic hypermutation in transformation of follicular lymphoma. Leukemia Res. 2008;32(7):1015–1021.CrossRefGoogle Scholar
  25. 25.
    Rossi D, Berra E, Cerri M. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. Haematologica. 2006;91(10):1405–1409.PubMedGoogle Scholar
  26. 26.
    Höglund M, Sehn L, Connors JM. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer. 2004;39(3):195–204.CrossRefPubMedGoogle Scholar
  27. 27.
    Cheung KJ, Shah SP, Steidl C. Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances. Blood. 2009;113(1):137–148.CrossRefPubMedGoogle Scholar
  28. 28.
    Ross CW, Ouillette PD, Saddler CM, Shedden KA, Malek SN. Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis. Clin Cancer Res. 2007;13(16):4777–4785.CrossRefPubMedGoogle Scholar
  29. 29.
    Fitzgibbon J, Iqbal S, Davies A. Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma. Leukemia. 2007;21(7):1514–1520.CrossRefPubMedGoogle Scholar
  30. 30.
    O’Shea D, O’Riain C, Taylor C. The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and a poorer overall survival. Blood. 2008;112(8):3126–3129.CrossRefPubMedGoogle Scholar
  31. 31.
    Zhu D, McCarthy H, Ottensmeier CH, Johnson P, Hamblin TJ, Stevenson FK. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood. 2002;99(7):2562–2568.CrossRefPubMedGoogle Scholar
  32. 32.
    Lenz G, Nagel I, Siebert R. Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med. 2007;204(3):633–643.CrossRefPubMedGoogle Scholar
  33. 33.
    Vaandrager J-W, Schuuring E, Kluin-Nelemans HC, Dyer MJ, Raap AK, Kluin PM. DNA fiber fluorescence in situ hybridization analysis of immunoglobulin class switching in B-cell neoplasia: aberrant CH gene rearrangements in follicle center-cell lymphoma. Blood. 1998;92(8):2871–2878.PubMedGoogle Scholar
  34. 34.
    Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N Engl J Med. 1984;311(23):1471–1475.CrossRefPubMedGoogle Scholar
  35. 35.
    Dave SS, Wright G, Tan B. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351(21):2159–2169.CrossRefPubMedGoogle Scholar
  36. 36.
    Glas AM, Kersten MJ, Delahaye LJ. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood. 2005;105(1):301–307.CrossRefPubMedGoogle Scholar
  37. 37.
    Lossos IS, Levy R. Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Semin Cancer Biol. 2003;13(3):191–202.CrossRefPubMedGoogle Scholar
  38. 38.
    Lossos IS, Levy R. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5′ noncoding regulatory region of the BCL-6 gene. Blood. 2000;96(2):635–639.PubMedGoogle Scholar
  39. 39.
    de Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol. 2005;23(26):6358–6363.CrossRefPubMedGoogle Scholar
  40. 40.
    Horsman DE, Okamoto I, Ludkovski O. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes. Br J Haematol. 2003;120(3):424–433.CrossRefPubMedGoogle Scholar
  41. 41.
    Weinberg OK, Ai WZ, Mariappan MR, Shum C, Levy R, Arber DA. “Minor” BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases. J Mol Diagn. 2007;9(4):530–537.CrossRefPubMedGoogle Scholar
  42. 42.
    Buchonnet G, Jardin F, Jean N, et al. Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease? Leukemia. 2002;16(9):1852–1856.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • W. Richard Burack
    • 1
  1. 1.Department of Pathology and Laboratory MedicineStrong Memorial Hospital, University of RochesterRochesterUSA

Personalised recommendations